MELISSA MANHART: Open Payments
NPI 1679786990 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 14 payments from 9 companies in 2025. Trend: 2023 $967 · 2024 $1,034 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $67 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Exact Sciences Corporation | 1 | $19 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
Products named: FREESTYLE LIBRE 3, REXULTI, Auvelity, The Cologuard Plus Collection Kit, TZIELD, TRINTELLIX, VRAYLAR.
Industry payments across MO — which companies pay providers there.
